Paul Diehl is a San Francisco-area biotech consultant with more than 20 years of experience in the field.
- Ph.D. in biochemistry from Washington State University
- Worked with numerous biotech companies
Paul Diehl, a San Francisco-area biotech consultant wrote about biotech and biomedical topics for The Balance from April 2012 to March 2014. His 20-plus years in the field include assessing, introducing, and supporting new technology for life science research. He has held various marketing and business development positions at B-Bridge International, Arcturus Bioscience, Agilent Laboratories, Display Systems Biotech, and Clontech Laboratories, as well as worked with several other companies on a contract basis. He has also published a number of freelance and contracted articles reviewing laboratory products, new therapeutics, and research developments.
Bachelor's degree in biology from LaSalle University
Ph.D. in Biochemistry from Washington State University
About The Balance and Dotdash
The Balance makes personal finance easy to understand. It is home to experts who provide clear, practical advice on managing your money. Whether you’re looking to invest, buy a home, save for retirement, or achieve another financial goal, The Balance will answer your questions with straightforward personal financial advice.
The Balance is part of the Dotdash publishing family. For more than 20 years, Dotdash brands have been helping people find answers, solve problems, and get inspired. We are one of the top-20 largest content publishers on the internet, according to comScore, and reach more than 30% of the U.S. population every month. Most recently, Dotdash was named Publisher of the year by Digiday, a leading industry publication.